| Ad Title: |
Cognitive Therapy for Recurrent Depression |
| Study Title: |
Prophylactic Cognitive Therapy for Depression and Are Cognitive Therapy's Antidepressant Effects Durable? |
| Protocol Number: |
0797-29100 |
| Department(s) involved in the Study: |
Psychiatry
|
| Purpose of the Study: |
The study will address whether booster sessions or medication will help individuals avoid relapse (return) of depression. |
| Participant Eligibility: |
-Recurrent unipolar major depressive disorder
-Have experienced at least two episodes of major depression
-Willing and able to comply with all study requirements
-Will be without current psychiatric treatment
-No current history of alcohol or drug dependence
-Able to speak and read English
|
| Disease/Condition Under Study: |
Mood disorders
Depression |
| Cancer Related Study: |
No
|
| Study Drug(s): |
Fluoxetine/Prozac
|
| Study Device(s): |
|
| Study Doctor: |
Dr. Robin Jarrett |
| Location of Study: |
|
Sites
|
Recruiting at this Site
|
|
University of Texas Southwestern Medical Center
|
Yes
|
|
| Contact Phone: |
214-648-5351 |
| Email: |
nancy.cravens@utsouthwestern.edu |
| Other Information: |
The Psychosocial Research and Depression Clinic in the Department of Psychiatry at The University of Texas Southwestern Medical Center at Dallas is conducting research on cognitive therapy to treat people who have been depressed more than once in their lives. Cognitive therapy is a short-term, talking therapy that focuses on negative patterns of thinking and develops coping skills.
Eligible individuals receive 16 or 20 sessions of cognitive therapy over 12 weeks. Evaluation and treatment are provided at no cost. After 16 or 20 sessions of therapy, eligible individuals will be followed for 8 more months and receive booster sessions of cognitive therapy, medication (Prozac), or sugar pill placebo.
|
| Website Keywords: |
Psychiatry
|
| Medical Keywords: |
cognitive therapy, Depression, Mood disorders
|
